A genetic variation associated with plasma erythropoietin and a non-coding transcript of PRKAR1A in sickle cell disease

Blood erythropoietin (EPO) increases primarily to hypoxia. In sickle cell anaemia (homozygous HBB(E6V); HbSS), plasma EPO is elevated due to hemolytic anaemia-related hypoxia. Hydroxyurea treatment reduces haemolysis and anaemia by increasing foetal haemoglobin, which leads to lower hypoxic transcri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hum Mol Genet
Main Authors: Zhang, Xu, Shah, Binal N., Zhang, Wei, Saraf, Santosh L., Miasnikova, Galina, Sergueeva, Adelina, Ammosova, Tatiana, Niu, Xiaomei, Nouraie, Mehdi, Nekhai, Sergei, Castro, Oswaldo, Gladwin, Mark T., Prchal, Josef T., Garcia, Joe G. N., Machado, Roberto F., Gordeuk, Victor R.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Association Studies Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078595/
https://ncbi.nlm.nih.gov/pubmed/28173069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddw299
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki